Trials / Unknown
UnknownNCT00916695
Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques
Everolimus-Eluting Stent in the Treatment of Bifurcation Lesions: Comparison of Main Vessel Stent to Main Vessel and Side Branch Stent
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 332 (estimated)
- Sponsor
- Spanish Society of Cardiology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of the treatment of true bifurcation lesions with the XIENCE V stent using the simple strategy (stent in main vessel and provisional T-stenting in the side branch) compared to the complex strategy (stent in main vessel and T-stenting in the side branch).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Xience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A. | Complex PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), and subsequent implanting of the stent in the main vessel, the side branch is approached by implanting a new stent as T technique. Simple PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), a stent is deployed at main vessel. Side branch is approached by using provisional T stenting technique. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2009-06-09
- Last updated
- 2009-07-23
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00916695. Inclusion in this directory is not an endorsement.